IL27 Receptor alpha anticorps (C-Term)
Aperçu rapide pour IL27 Receptor alpha anticorps (C-Term) (ABIN6242398)
Antigène
Voir toutes IL27 Receptor alpha (IL27RA) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 569-602, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This IL27RA antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 569-602 amino acids from the C-terminal region of human IL27RA.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
- IL27 Receptor alpha (IL27RA) (Interleukin 27 Receptor, alpha (IL27RA))
-
Autre désignation
- IL27RA
-
Sujet
- Receptor for IL27. Requires IL6ST/gp130 to mediate signal transduction in response to IL27. This signaling system acts through STAT3 and STAT1. Involved in the regulation of Th1- type immune responses. Also appears to be involved in innate defense mechanisms.
-
Poids moléculaire
- 69474
-
UniProt
- Q6UWB1
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response
Antigène
-